Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain

Neuro-Oncology

Volumn 15, Issue 6, 2013, Pages 797-805

  Graus, Francesc ^a   Bruna, Jordi ^b   Pardo, Javier ^c   Escudero, Domingo ^d   Vilas, Dolores ^d   Barceló, Inés ^e   Brell, Marta ^e   Pascual, Carmen ^f   Crespo, José A ^f   Erro, Elena ^g   García Romero, Juan C ^g   Estela, Jordi ^h   Martino, Juan ⁱ   García Castaño, Almudena ⁱ   Mata, Elena ⁱ   Lema, Manuela ^j   Gelabert, Miguel ^j   Fuentes, Rafel ^k   Pérez, Pedro ^l   Manzano, Arancha ^l   Aguas, Jesús ^m   Belenguer, Antonio ⁿ   Simón, Ana ⁿ   Henríquez, Iván ^o   Murcia, Mauricio ^o   Vivanco, Rosa ^p   Rojas Marcos, Iñigo ^q   Muñoz Carmona, David ^q   Navas, Inmaculada ^r   De Andrés, Pablo ^s   Mas, Gemma ^t   Gil, Miguel ^u   Verger, Eugènia ^a   more..

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g Instituto de Investigación Sanitaria de Navarra   (Spain)

^h HOSPITAL DE SABADELL   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k HOSPITAL JOSEP TRUETA   (Spain)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁿ HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^o HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^p HOSPITAL DEL MAR   (Spain)

^q HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^r Service of Neurology   (Spain)

^s Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^t HOSPITAL FRANCESC DE BORJA   (Spain)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

more..

Author keywords

glioblastoma multiforme; older patients; practice patterns; radiotherapy delay; surgical complications

Indexed keywords

BEVACIZUMAB; CARMUSTINE; CILENGITIDE; IRINOTECAN; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL (TOPIC); FEMALE; GLIOBLASTOMA; HEMATOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIQUORRHEA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; RADIOSURGERY; RETROSPECTIVE STUDY; SEIZURE; SPAIN; TREATMENT OUTCOME;

GLIOBLASTOMA MULTIFORME; OLDER PATIENTS; PRACTICE PATTERNS; RADIOTHERAPY DELAY; SURGICAL COMPLICATIONS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; RETROSPECTIVE STUDIES; SPAIN; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84878331540     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not013     Document Type: Article

References (37)

1. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005; 109: 93-108.
2. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005; 64: 479-489.
3. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10: 459-466.
4. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987-996.
5. Yabroff KR, Harlan L, Zeruto C, Abrams J, Mann B. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006. Neuro-Oncol. 2012; 14: 351-359.
6. Darefsky AS, King JT, Jr, Dubrow R. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries. Cancer. 2012; 118: 2163-2172.
7. Koshy M, Villano JL, Dolecek TA, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012; 107: 207-212.
8. Rønning PA, Helseth E, Meling TR, Johannesen TB. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. Neuro-Oncol. 2012; 14: 1178-1184.
9. Laperriere N, Weller M, Stupp R, et al. Optimal management of elderly patients with glioblastoma. Cancer Treat Rev. 2012;.
10. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998; 42: 1044-1055.
11. Blumenthal DT, Won M, Mehta MP, et al. Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol. 2009; 27: 733-739.
12. Bauchet L, Mathieu-Daudé H, Fabbro-Peray P, et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro-Oncol. 2010; 12: 725-735.
13. Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005; 293: 557-564.
14. Rosenthal MA, Drummond KJ, Dally M, et al. Management of glioma in Victoria (1998-2000): retrospective cohort study. MJA. 2006; 184: 270-273.
15. Salmaggi A, Silvani A, Merli R, et al. Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience. Neurol Sci. 2008; 29: 77-83.
16. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008; 62: 564-576.
17. Ulmer S, Braga TA, Barker FG, et al. Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology. 2006; 67: 1668-1670.
18. Arrigo RT, Boakye M, Skirboll SL. Patterns of care and survival of glioblastoma patients in the Veterans population. J Neurooncol. 2012; 106: 627-635.
19. Filippini G, Falcone Ch, Boiardi A, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro-Oncol. 2008; 10: 79-87.
20. Chang S, Parney IF, MCDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003; 98: 1175-1181.
21. Gulati S, Jakola AS, Nerland US, Weber C, Solheim O. The risk of getting worse: Surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg. 2011; 76: 572-579.
22. Braker FG, II, Curry WT, Jr, Carter BS. Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: The effect of provider caseload and centralization of care. Neuro-Oncol. 2005; 6: 49-63.
23. Cowan JA, Jr, Dimick JB, Leveque JCH, et al. The impact of provider volume on mortality and intracranial tumor resection. Neurosurgery. 2003; 52: 48-54.
24. Long DM, Gordon T, Bowman H, et al. Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery. 2003; 52: 1056-1065.
25. Lawrence YR, Blumenthal DT, Matceyevsky D, et al. Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line? J Neurooncol. 2011; 105: 1-7.
26. Noel G, Huchet A, Feuvret L, et al. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. J Neurooncol. 2012; 109: 167-175.
27. Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol. 2007; 85: 339-343.
28. Chargari C, Feuvret L, Bauduceau O, et al. Treatment of elderly patients with glioblastoma: From clinical evidence to molecular highlights. Cancer Treat Rev. 2012; 38: 988-995.
29. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007; 356: 1527-1535.
30. WickW, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012; 13: 707-715.
31. Malmstrom A, Grønberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol. 2012; 13: 916-926.
32. Reifenberger G, Hentschel B, Felsberg J, et al. Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer. 2012; 131: 1342-1350.
33. Floyd SR, Kasper EM, Uhlmann EJ, et al. Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients - Early results of a phase II trial. Front Oncol. 2012; 2: 122.
34. Barker CA, Chang M, Chou JF, et al. Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol. 2012; 109: 391-397.
35. Brandes AA, Franceschi E, Tosoni A, et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer. 2009; 115: 3512-3518.
36. Minniti G, De Sanctis V, Muni R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol. 2008; 88: 97-103.
37. Combs SE, Wagner J, Bischof M, et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys. 2008; 70: 987-992.